| 1 |
New Online Export NOC System on SUGAM Portal |
2025-Mar-07 |
|
5412 KB |
| 2 |
Launching of registration of Clinical Research Organisation applications through SUGAM Portal |
2025-Mar-04 |
|
1867 KB |
| 3 |
Submission of clinical trial site addition and change of principal Investigator applications through sugam portal |
2025-Feb-24 |
|
57 KB |
| 4 |
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country without due approval from Central Licensing Authority 24 Feb 2025 |
2025-Feb-24 |
|
1884 KB |
| 5 |
Prohibits to manufacture, sale and distribution and use of drug Nimesulide and its formulation for animal use with immediate effect |
2025-Feb-20 |
|
287 KB |
| 6 |
Inviting stakeholders comments for Invitro Diagnostic Medical Device adverse event reporting form |
2025-Feb-17 |
|
325 KB |
| 7 |
Procedure to be followed for subsequent applicant in respect of FDCs declared as rational by Prof. Kokate Committee and approved by DCG(I) |
2025-Feb-04 |
|
3922 KB |
| 8 |
Inviting comments on standard IVD evaluation protocol drafted by ICMR and CDSCO 2 |
2025-Jan-29 |
|
1704 KB |
| 9 |
Guidance document Validation of Rapid Diagnostics for Pathogen Identification and Antimicrobial Susceptibility Testing (AST) |
2025-Jan-16 |
|
2642 KB |
| 10 |
Updation of exisiting risk based classification list_draft_dated 06 01 2025 for stakeholder comments |
2025-Jan-06 |
|
3025 KB |
